‘Life-changing’ drug for sickle cell disease to be offered by NHS in England
Voxelotor, which can help reduce need for blood transfusions, is administered as a daily tablet
Voxelotor, which can help reduce need for blood transfusions, is administered as a daily tablet
The new algorithm from Implicity evaluates implantable device data and monitors patients for changes that suggest they could experience severe heart failure symptoms in the near…
To assess tissue Doppler-derived mitral annular isovolumic contraction velocity (ICV) after starting sacubitril/valsartan (sac/val) for the treatment of heart failure with reduced ejection fraction (HFrEF)…
Glyphosate found in samples from French infertility clinic raising questions about controversial chemical’s impact on fertility
Background Elevated heart rate (HR) predicts cardiovascular disease and mortality, but there are no established normal limits for ambulatory HR. We used data from the…
This feature about an attending preparing for her upcoming week of service offers a case vignette accompanied by two essays, one supporting visiting patients early…
Sudden cardiac death in children and young adults is a relatively rare but tragic event whose pathophysiology is unknown at the molecular level. Evidence indicates…
This is a resection of a popliteal artery aneurysm associated with a massive extremity arteriovenous malformation. Objectives:1. Describe the safe resection …
The new fiber-optic probe could transform aneurysm and brain clot treatments
Some cautioned against reading too much into this analysis, since the main trial did not meet its primary endpoint.
Implantable cardioverter-defibrillators last longer, and interest in reliable leads with targeted lead placement is growing. The OmniaSecure™ defibrillation lead is a novel small-diameter, catheter-delivered lead…